Skip to main content

Health condition · Clinically reviewed

Hypoparathyroidism, low calcium, high phosphate - and how it is treated today.

Mostly a consequence of neck surgery, sometimes autoimmune or genetic. A careful medical plan with calcium, activated vitamin D and, for some, recombinant PTH keeps it well controlled.

Jump to treatment
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Clinically reviewed

    Written by our editorial team and reviewed by a registered UK clinician before publication.

  • 02

    Sourced from guidance

    Checked against ESE, BSPED and peer-reviewed endocrinology sources you can see at the end.

  • 03

    Current for 2026

    Reflects modern UK endocrine practice, including activated vitamin D therapy and emerging recombinant PTH options.

Key facts

Hypoparathyroidism at a glance.

The essentials, in plain English - what it is, why it happens and how it is treated in the UK today.

  • What it is

    Deficient parathyroid hormone leading to hypocalcaemia, hyperphosphataemia and normal or low active vitamin D.

  • Commonest cause

    Post-surgical, typically after total thyroidectomy or parathyroidectomy - accounting for around three quarters of cases.

  • Other causes

    Autoimmune (including APS-1), congenital syndromes such as DiGeorge, infiltrative disease, familial and idiopathic.

  • Foundation therapy

    Oral calcium plus activated vitamin D (alfacalcidol or calcitriol), titrated to symptoms and biochemistry.

  • Emerging therapy

    Recombinant PTH options such as palopegteriparatide (Yorvipath) for selected patients under specialist care.

  • Monitoring

    Regular calcium, phosphate, magnesium, renal function and urinary calcium - long-term specialist follow-up.

Why this guide matters

A treatable condition, if it is looked for.

Symptoms of low calcium can be dismissed as anxiety or fatigue. A careful history, a targeted set of blood tests and specialist follow-up change that.

  • Neck surgery is the biggest clue

    Any patient with numbness, cramps or brain fog after thyroid or parathyroid surgery needs urgent calcium and PTH testing.

  • Activated vitamin D is essential

    Because PTH is low, the body cannot fully activate ordinary vitamin D - alfacalcidol or calcitriol does that job.

  • Kidneys and bones deserve attention

    Long-term monitoring of urinary calcium, kidney function and bone density is designed to prevent nephrocalcinosis and CKD.

How the diagnosis is made

From first symptoms to a clear plan.

The steps a UK GP and endocrinologist will normally follow, in order, so you know what to expect and why.

  1. 01

    Assessing

    History and surgical review

    Previous neck surgery, family history, medications and magnesium status are the first clues to hypoparathyroidism.

  2. 02

    Assessing

    Examination for tetany signs

    Chvostek and Trousseau signs point to neuromuscular irritability from low calcium.

  3. 03

    Assessing

    Corrected and ionised calcium

    A low corrected or ionised calcium with a low or inappropriately normal PTH clinches the diagnosis.

  4. 04

    Confirming

    Phosphate, magnesium, vitamin D

    High phosphate with low or normal 25-OH vitamin D and low magnesium can all shape treatment.

  5. 05

    Confirming

    ECG and urinary calcium

    A prolonged QT interval and 24-hour urinary calcium guide urgency and long-term monitoring.

  6. 06

    Specialising

    Genetic testing where indicated

    Selective testing for AIRE (APS-1), 22q11.2 (DiGeorge), GCM2, CaSR or GNAS mutations, arranged through specialist commissioned services.

  7. 07

    Specialising

    Specialist MDT input

    Complex or emerging therapy cases are managed by a commissioned endocrine service with input from renal and genetics teams.

Typical timeline: initial diagnosis in days, long-term care shared between GP and endocrinologist.

Symptoms

What hypoparathyroidism feels like.

Symptoms range from mild tingling and cramp to seizures and airway spasm. Long-standing disease can affect eyes, teeth and the brain.

  • Perioral and digital paraesthesia

    Tingling around the mouth and in the fingers and toes is often the first symptom of hypocalcaemia.

  • Cramping and tetany

    Muscle cramps, carpopedal spasm and frank tetany reflect the neuromuscular effects of low calcium.

  • Chvostek and Trousseau signs

    Facial twitch on tapping the facial nerve and carpal spasm with a blood pressure cuff support the diagnosis.

  • Seizures and laryngospasm

    Severe hypocalcaemia can trigger seizures or laryngospasm - a medical emergency needing intravenous calcium.

  • Prolonged QT and arrhythmias

    Low calcium prolongs the QT interval and, uncorrected, can lead to serious arrhythmias.

  • Basal ganglia calcification

    Long-standing disease can lead to intracranial calcification, with movement or cognitive symptoms in some patients.

  • Cataracts and dental changes

    Cataracts, enamel hypoplasia and brittle nails or hair reflect chronic calcium and phosphate imbalance.

  • Red flag - severe or acute hypocalcaemia

    Seizures, tetany, laryngospasm or a very low calcium after neck surgery needs emergency assessment.

Treatment

How hypoparathyroidism is treated in the UK.

Calcium and activated vitamin D are the mainstay. Magnesium correction, thiazide diuretics and recombinant PTH have specific roles for selected patients.

  • Oral calcium

    Calcium carbonate or citrate, typically 1 to 2 grams a day in divided doses, titrated to symptoms and blood levels.

  • Activated vitamin D

    Alfacalcidol or calcitriol under specialist prescribing - bypasses the impaired 1-alpha-hydroxylation seen in hypoparathyroidism.

  • Cholecalciferol

    Standard vitamin D3 supplementation used alongside activated vitamin D to correct any 25-OH deficiency.

  • Magnesium correction

    Low magnesium blocks PTH action and must be corrected before calcium will respond fully to treatment.

  • Thiazide diuretic

    Hydrochlorothiazide reduces urinary calcium loss and is used in selected patients under specialist review.

  • IV calcium gluconate

    For acute severe or symptomatic hypocalcaemia, given in a monitored setting with cardiac observation.

  • Recombinant PTH (rhPTH)

    Palopegteriparatide (Yorvipath) is a long-acting rhPTH(1-84) option for selected patients under specialist commissioning; teriparatide is used off-label in some centres.

  • Long-term monitoring

    Regular calcium, phosphate, magnesium, creatinine, urinary calcium and bone density under specialist follow-up.

What this guide is based on

The sources behind every claim on this page.

UK and European specialist society standards and regulatory product information, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your GP or endocrinologist knows your history and can tell you which parts apply to you. If in doubt, ask to be seen.

  • European Society of Endocrinology (ESE). Clinical guideline for the management of chronic hypoparathyroidism in adults.

  • British Society for Paediatric Endocrinology and Diabetes (BSPED). Guidance on hypocalcaemia and hypoparathyroidism in children.

  • NHS England. Specialised endocrinology service specification.

  • MHRA and EMA. Product information for palopegteriparatide (Yorvipath) and teriparatide (Forsteo).

Red flags

When hypoparathyroidism needs urgent attention.

Most patients are stable on long-term therapy. These are the situations that need same-day or specialist review.

  • Post-thyroidectomy hypocalcaemia

    A sudden fall in calcium after neck surgery is an emergency - urgent bloods, ECG and specialist review are needed.

  • Seizures or laryngospasm

    Severe hypocalcaemia can present with seizures or airway spasm - a medical emergency requiring IV calcium.

  • Prolonged QT interval

    A prolonged QT on ECG raises the risk of serious arrhythmias and needs prompt correction.

  • Nephrocalcinosis or CKD

    High urinary calcium can cause kidney stones and progressive kidney damage - a key reason for careful monitoring.

  • Basal ganglia calcification

    Long-standing untreated disease can lead to intracranial calcification and neurological symptoms.

  • Suspected APS-1

    Hypoparathyroidism with mucocutaneous candidiasis or adrenal insufficiency suggests APS-1 - specialist commissioned genetics is warranted.

  • Pregnancy

    Calcium needs change through pregnancy and the puerperium - joint endocrine and obstetric care is essential.

  • Pseudohypoparathyroidism

    Low calcium with a high PTH and features of Albright hereditary osteodystrophy needs genetic and specialist review.

  • Hypomagnesaemia

    Persistently low magnesium blocks PTH release and action - always correct it before escalating other therapy.

Living with it

A long-term condition, with a steady rhythm.

Four things that make the biggest difference day to day - consistent medication, regular monitoring, knowing your symptoms and staying connected to support.

A quiet reminder

Small, steady habits protect your kidneys and bones.

Consistent dosing and monitoring do more than perfect numbers on one blood test.

  1. 01 Routine

    Take medication consistently

    Calcium and activated vitamin D are lifelong for most people - a steady daily routine keeps levels stable.

  2. 02 Monitoring

    Keep to blood test schedules

    Regular calcium, phosphate, magnesium, kidney and urinary calcium tests protect your bones and kidneys.

  3. 03 Symptoms

    Know your warning signs

    Tingling, cramps or brain fog often mean calcium is drifting low - contact your endocrine team promptly.

  4. 04 Support

    Connect with Hypoparathyroidism UK

    Patient organisations offer practical advice, peer support and up-to-date information on emerging therapies.

Frequently asked

Everything we get asked about hypoparathyroidism.

Quick answers on causes, diagnosis, calcium and vitamin D therapy, and newer recombinant PTH options.

  • What is hypoparathyroidism?

    It is a condition where the parathyroid glands make too little parathyroid hormone (PTH). This leads to low blood calcium, high phosphate and, over time, symptoms ranging from tingling and cramps to seizures, cataracts and kidney problems.

  • What causes hypoparathyroidism?

    The most common cause is damage or removal of the parathyroid glands during neck surgery, particularly thyroidectomy or parathyroidectomy. Other causes include autoimmune disease (such as APS-1), congenital syndromes like DiGeorge, infiltrative diseases including haemochromatosis and Wilson disease, familial genetic causes, radiation and, rarely, idiopathic disease. Pseudohypoparathyroidism is a related condition where PTH is high but the body cannot respond to it.

  • How is it diagnosed?

    The diagnosis rests on blood tests showing a low corrected or ionised calcium with a low or inappropriately normal PTH, usually alongside a high phosphate. Magnesium, vitamin D, kidney function, urinary calcium and an ECG are checked. Selective genetic testing is arranged through specialist commissioned services when a hereditary cause is suspected.

  • How is it treated in the UK?

    Standard treatment combines oral calcium with an activated vitamin D such as alfacalcidol or calcitriol, prescribed and monitored by an endocrinologist. Cholecalciferol and magnesium are corrected as needed, and thiazide diuretics can help patients with high urinary calcium. Severe episodes need intravenous calcium gluconate in hospital.

  • Are there newer treatments?

    Recombinant PTH therapies are an emerging option for selected patients whose calcium and phosphate are hard to control on standard therapy. Palopegteriparatide (Yorvipath) is a long-acting rhPTH(1-84) approved by the FDA in 2024 and available in the UK through specialist commissioned services; teriparatide (Forsteo) is used off-label in some centres. Natpara has been discontinued.

  • What long-term problems can hypoparathyroidism cause?

    Poorly controlled disease can lead to kidney stones, nephrocalcinosis and chronic kidney disease, cataracts, basal ganglia calcification, arrhythmias and dental abnormalities. Regular monitoring of calcium, phosphate, magnesium, kidney function and urinary calcium, alongside specialist follow-up, is designed to prevent these complications.

Related content

Keep reading.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

We reply to every enquiry within 24 hours (Mon–Fri). Confidential - your details are never shared outside our vetted consultant network.